
ServicesBruce McManus Cardiovascular Biobank
About the Biobank
The Bruce McManus Cardiovascular Biobank (BMCB), initiated by Dr. Bruce McManus in June 1982, maintains over 100,000 de-identified human cardiovascular tissue specimens, including explanted hearts from orthotopic heart transplantation, blood vessels, heart valves, and myocardium. The BMCB has been a platform for translational research and multi-faceted education.
Archiving Tissue Specimens
In close collaboration with heart surgeons and pathologists, the BMCB collects human tissue specimens directly from the Operating Room, typically within 5 minutes post-surgery. Each specimen is processed through four distinct preservation methods, ensuring the integrity and utility of samples for research purposes. These methods include:
- flash-freezing,
- RNA stabilization solution (RNAlater™) storage,
- Optimal Cutting Temperature (OCT) compound-embedded, and
- formalin-fixed paraffin-embedded (FFPE)
The BMCB’s distinguished heart transplant cohort is characterized by the collection of explanted hearts, kindly donated by transplant recipients, alongside matched blood samples from the donors. For each heart, we archive tissues from 32 standardized regions in each of the four preservation methods previously described (Fig. 1). Our biobanking approach is illustrated in the below figure, a visual representation of our heart archiving protocol.

Common Surgical Samples Available
This list highlights common specimens routinely collected at the BMCB, but is not exhaustive. Please contact the biobank for information on additional available sample types.
Requesting Sample Access
All initial requests should go to our centralized service email biobank@hli.ubc.ca. For samples from explanted hearts, please have a look at the Clinical Data Collection Form and Sample Request Form attached below to know what information and samples may be available for your research.
The BMCB supports cardiovascular research for local, national, and international investigators. The BMCB requires approved human ethics before releasing human biospecimens.
For UBC researchers, please refer to “Guidance Note 18: Research Involving Human Biospecimens” for your ethics approval or letters of ethics exemption. For non-UBC researchers, please refer to your local ethics requirement. BMCB will require your full ethics application or letter of ethics exemption before releasing any human biospecimens for research. The ethics documents need to come from an authorized ethics board and clearly indicate how samples will be used (e.g., purpose, assays, and dissemination of results).

Ying Wang
PhD, Scientific and Operations DirectorRoles: Projects and ethics assessment & Biobank operation
Dr. Wang’s research focuses on coronary artery disease and drug screening for cardiovascular disease.
For more details, please see:
https://wanglab.med.ubc.ca/

Chi Lai
MD, Medical DirectorRoles: Pathology assessment & Biobank operation
Dr. Lai is the current provincial lead for cardiovascular pathology and clinical professor at UBC Department of Pathology and Laboratory Medicine.
After completing his medical school and anatomical pathology residency training at McGill University, he did two clinical fellowships in transplantation pathology at the University of Pittsburgh Medical Center and cardiovascular/thoracic pathology at David Geffen School of Medicine at UCLA. Dr. Lai has nearly 20 years of post-fellowship clinical experience in cardiovascular/thoracic and general surgical pathology.

Gurpreet Singhera
PhD, Research and Education CoordinatorRoles: Patient consent and biobanking & Coordination of education events & MTA
Dr. Singhera brings 25 years of extensive experience in tissue and cell biobanking, lab management, project management, and inter-disciplinary collaborations.
She oversees the heart failure archiving team and facilitates cardiovascular research with the HLI community and external collaborators.
Sela Grays
BSc, Research CoordinatorRoles: Patient consent and research coordination
Sela holds a Bachelor’s of Science in Mathematics and Economics and joined the biobank in 2026.

Melody Cheng
MSc, Biobanking SpecialistRoles: Biobanking & Chart review
Melody brings 7 years of clinical experience in anatomical pathology and 3 years of research experience specializing in cardiovascular diseases.
She joined the BMCB in 2026 to support cardiovascular research through sample management and clinical chart review.

Julia Kong
BSc, Research AssistantRoles: SOPs & MTA
Julia Kong graduated from the University of British Columbia with a Bachelor of Science in Biochemistry. She joined the BMCB in July, 2026.
As a research assistant, she develops Standard Operating Procedures (SOPs) for biobanking with her expertise in cardiovascular disease and assists with Material Transfer Agreements (MTAs) to facilitate collaboration.









